Patent assignee · FR · COMPANY

AB SCIENCE

🏢 View company profile →
27Patents
22Active
27Granted
45Portfolio score

Filing activity: Jun 28, 2002 → Mar 24, 2017 · 8 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7718676B2 2-aminoaryloxazole compounds as tyrosine kinase inhibitors Chemistry; Metallurgy 29 Active
US10092564B2 Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation Human Necessities 8 Active
US7423055B2 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases Chemistry; Metallurgy 6 Expired
US8450302B2 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Chemistry; Metallurgy 5 Active
US8153792B2 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors Human Necessities 1 Active
US8492545B2 Aminothiazole compounds as kinase inhibitors and methods of using the same Human Necessities 1 Active
US7700610B2 Use of tyrosine kinase inhibitors for treating allergic diseases Physics 1 Expired
US8658659B2 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors Chemistry; Metallurgy 1 Active
US8227470B2 Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors Human Necessities 0 Active
US10053455B2 Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors Chemistry; Metallurgy 0 Active
US10238649B2 Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors Chemistry; Metallurgy 0 Active
US7678805B2 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD) Physics 0 Expired
US10392373B2 Oxazole derivatives that inhibit Syk Human Necessities 0 Active
US7741335B2 Use of tyrosine kinase inhibitors for treating inflammatory diseases Physics 0 Expired
US7727731B2 Potent, selective and non toxic c-kit inhibitors Physics 0 Expired
US9168245B2 Selective protein kinase inhibitors Chemistry; Metallurgy 0 Active
US9078894B2 Treatment of severe persistant asthma with masitinib Human Necessities 0 Active
US10570122B2 Compounds with anti-tumoral activity Chemistry; Metallurgy 0 Active
US8962665B2 Thiazole and oxazole kinase inhibitors Chemistry; Metallurgy 0 Active
US8835435B2 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Chemistry; Metallurgy 0 Active
US10045978B2 Treatment of mastocytosis with masitinib Human Necessities 0 Active
US8110591B2 2-aminoaryloxazole compounds as tyrosine kinase inhibitors Chemistry; Metallurgy 0 Active
US8080669B2 Process for the synthesis of 2-aminoxazole compounds Chemistry; Metallurgy 0 Active
US8993573B2 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors Chemistry; Metallurgy 0 Active
US8940894B2 Aminothiazole compounds as kinase inhibitors and methods of using the same Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.